Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
![Foto de José Luis](/img/nophoto.png)
José Luis
Lobo Beristain
Publicacións nas que colabora con José Luis Lobo Beristain (40)
2024
-
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152
-
Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis
Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
-
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry
Thrombosis Research
-
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823
2022
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
-
The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry
Thrombosis Research
2021
-
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416
2020
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry
Journal of Internal Medicine, Vol. 287, Núm. 1, pp. 32-41
-
Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score
European Respiratory Journal, Vol. 56, Núm. 6
-
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry
Thrombosis Update, Vol. 1
-
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry
Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 8, Núm. 3, pp. 353-359.e1
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine